Teva Pharmaceutical (NYSE:TEVA) is one of the most undervalued large cap stocks to buy according to analysts. On June 24, Teva Pharmaceutical announced the final analysis results from its PEARL Phase ...
(RTTNews) - Teva Pharmaceutical Industries Limited (TEVA), a commercial biopharmaceutical company, today, reported positive results from its SPACE study. SPACE study is a phase III trial evaluating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback